Search Results | Scholarly Articles, Journals, and E-Books

Results: 11

Pharmacological in vitro characterization of the arecoline bioisostere, Lu 25-109-T, a muscarinic compound with M1-agonistic and M2/M3-antagonistic properties.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 1, doi. 10.1002/(SICI)1098-2299(199701)40:1<1::AID-DDR1>3.0.CO;2-Q
By:
- Meier, Eddi;
- Frederiksen, Kristen;
- Nielsen, Mogens;
- Lembøl, Hanne Løve;
- Pedersen, Henrik;
- Hyttel, John
Publication type:
Article
Down-regulation of LPS-induced nitric oxide synthesis of murine macrophages by oral administration of Sho-saiko-to.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 48, doi. 10.1002/(SICI)1098-2299(199701)40:1<48::AID-DDR5>3.0.CO;2-T
By:
- Izumi, Shigeru;
- Ohno, Naohito;
- Yadomae, Toshiro
Publication type:
Article
Prevention and/or treatment of ischemic stroke with nitric oxide synthase substrates.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 88, doi. 10.1002/(SICI)1098-2299(199701)40:1<88::AID-DDR9>3.0.CO;2-P
By:
- Chiou, George C.Y.;
- Hong, Show-Jen
Publication type:
Article
Erratum: Sheardown MJ, Knutsen LJS (1996): Unexpected neuroprotection observed with the adenosine A2A receptor agonist CGS 21680. Drug Dev Res 39:108-114.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 99, doi. 10.1002/(SICI)1098-2299(199701)40:1<99::AID-DDR11>3.0.CO;2-C
By:
- Sheardown, Malcolm J.;
- Knutsen, Lars J.S.
Publication type:
Article
Screening for inhibitors of the HMG-CoA reductase promoter in HepG2 cells: Identification of four non-oxysterol inhibitors.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 41, doi. 10.1002/(SICI)1098-2299(199701)40:1<41::AID-DDR4>3.0.CO;2-T
By:
- Yagi, Yoshihiko;
- Bevis, Debra J.;
- Hart, Karen L.;
- Hess, Gerard F.;
- Dinh, Dac M.;
- Keiser, Barbara J.;
- Larsen, Scott D.;
- Spilman, Charles H.
Publication type:
Article
Subchronic toxicity and reversibility of WR6026 dihydrochloride, an 8-aminoquinoline antileishmanial drug, in rats and dogs.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 75, doi. 10.1002/(SICI)1098-2299(199701)40:1<75::AID-DDR8>3.0.CO;2-Q
By:
- Levine, Barry S.;
- Furedi-Machacek, E. Marianna;
- Brown, Alan P.;
- Tomlinson, Michael J.
Publication type:
Article
Electrophysiological effects of Gallanilide on cardiac ventricular and Purkinje fibers.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 94, doi. 10.1002/(SICI)1098-2299(199701)40:1<94::AID-DDR10>3.0.CO;2-H
By:
- Shang-Zhong, Xu;
- Xin-Ying, Zhu;
- Shou-Qi, Yan
Publication type:
Article
Binding of [125I] AB-MECA to the human cloned adenosine A3 receptor using the semliki forest virus expression system.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 35, doi. 10.1002/(SICI)1098-2299(199701)40:1<35::AID-DDR3>3.0.CO;2-U
By:
- Patel, M.;
- Harris, C.;
- Lundstrom, K.
Publication type:
Article
Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 68, doi. 10.1002/(SICI)1098-2299(199701)40:1<68::AID-DDR7>3.0.CO;2-R
By:
- Rapin, Jean R.;
- Yoa, René G.;
- Bouvier, Christine;
- Drieu, Katy
Publication type:
Article
Pharmacological profile of LY301317, a potent and selective 5-HT1A agonist.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 17, doi. 10.1002/(SICI)1098-2299(199701)40:1<17::AID-DDR2>3.0.CO;2-W
By:
- Wolff, Mary C.;
- Benvenga, Mark J.;
- Calligaro, David O.;
- Fuller, Ray W.;
- Gidda, Jaswant S.;
- Hemrick-Luecke, Susan;
- Lucot, James B.;
- Nelson, David L.;
- Overshiner, Carl D.;
- Leander, J. David
Publication type:
Article
Percutaneous absorption and skin erythema: Quantification of capsaicin and its synthetic derivatives from gels incorporated with benzalkonium chloride by using non-invasive bioengineering methods.
Published in:
Drug Development Research, 1997, v. 40, n. 1, p. 56, doi. 10.1002/(SICI)1098-2299(199701)40:1<56::AID-DDR6>3.0.CO;2-S
By:
- Fang, Jia-You;
- Tsai, Ming-Jun;
- Huang, Yaw-Bin;
- Wu, Pao-Chu;
- Tsai, Yi-Hung
Publication type:
Article

Pharmacological in vitro characterization of the arecoline bioisostere, Lu 25-109-T, a muscarinic compound with M<sub>1</sub>-agonistic and M<sub>2</sub>/M<sub>3</sub>-antagonistic properties.

Down-regulation of LPS-induced nitric oxide synthesis of murine macrophages by oral administration of Sho-saiko-to.

Prevention and/or treatment of ischemic stroke with nitric oxide synthase substrates.

Erratum: Sheardown MJ, Knutsen LJS (1996): Unexpected neuroprotection observed with the adenosine A<sub>2A</sub> receptor agonist CGS 21680. Drug Dev Res 39:108-114.

Screening for inhibitors of the HMG-CoA reductase promoter in HepG2 cells: Identification of four non-oxysterol inhibitors.

Subchronic toxicity and reversibility of WR6026 dihydrochloride, an 8-aminoquinoline antileishmanial drug, in rats and dogs.

Electrophysiological effects of Gallanilide on cardiac ventricular and Purkinje fibers.

Binding of [<sup>125</sup>I] AB-MECA to the human cloned adenosine A<sub>3</sub> receptor using the semliki forest virus expression system.

Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat.

Pharmacological profile of LY301317, a potent and selective 5-HT<sub>1A</sub> agonist.

Percutaneous absorption and skin erythema: Quantification of capsaicin and its synthetic derivatives from gels incorporated with benzalkonium chloride by using non-invasive bioengineering methods.